Combine contrast-enhanced 3D T2-weighted short inversion time inversion recovery MR neurography with MR angiography at 1.5 T in the assessment of brachial plexopathy
Purpose To explore the benefits of using a single injection of contrast agent at a 1.5 T system to perform both contrast-enhanced MR angiography (MRA) and 3D-T2-STIR MR neurography (MRN) to assess of brachial plexopathy. Methods In this prospective study, 27 patients with suspected brachial plexopathy, received an imaging procedure composed sequentially of non-enhanced 3D-T2-STIR, CE-MRA, and contrast-enhanced 3D-T2-STIR, using a 1.5 T MR scanner. Signal intensities and contrast ratios were compared with and without contrast agent. The non-enhanced and contrast-enhanced 3D-T2-STIR images were mixed for two experienced radiologists to rate image diagnostic quality in a blind manner. 3D images of MRN and MRA were merged to reveal the spatial relation between brachial plexopathy and concomitant vascular disorders. Results By comparing the non-enhanced with contrast-enhanced 3D-T2-STIR images, it revealed that the use of the contrast agent in 3D-T2-STIR MRN could significantly suppress the background signals contributed by small vein (P < 0.001), lymph node (P < 0.001), muscle (P < 0.001) and bone (P < 0.001). This improved the contrast ratios between the brachial plexus and its surrounding tissues (P < 0.001) and boosted the image’s quality score (P < 0.01). Examining both CE-MRA and 3D-T2-STIR images revealed a relatively high incidence of concurrent vascular dysfunction in brachial plexopathy, with 39% of confirmed cases accompanied with subclavian and axillary vessel abnormalities. Conclusion Combining contrast-enhanced 3D-T2-STIR MRN with MRA at a 1.5 T system significantly suppresses background signals, improves brachial-plexus display, and provides a direct assessment for both brachial plexus lesion and surrounding vascular injury..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Magnetic resonance materials in physics, biology and medicine - 34(2020), 2 vom: 13. Juli, Seite 229-239 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xu, Zhengdao [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Brachial plexopathy |
| doi: |
10.1007/s10334-020-00867-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR043681948 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR043681948 | ||
| 003 | DE-627 | ||
| 005 | 20230519141337.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210403s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10334-020-00867-z |2 doi | |
| 035 | |a (DE-627)SPR043681948 | ||
| 035 | |a (DE-599)SPRs10334-020-00867-z-e | ||
| 035 | |a (SPR)s10334-020-00867-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |a 570 |a 530 |q ASE |
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 33.07 |2 bkl | ||
| 084 | |a 35.25 |2 bkl | ||
| 084 | |a 44.64 |2 bkl | ||
| 100 | 1 | |a Xu, Zhengdao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Combine contrast-enhanced 3D T2-weighted short inversion time inversion recovery MR neurography with MR angiography at 1.5 T in the assessment of brachial plexopathy |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Purpose To explore the benefits of using a single injection of contrast agent at a 1.5 T system to perform both contrast-enhanced MR angiography (MRA) and 3D-T2-STIR MR neurography (MRN) to assess of brachial plexopathy. Methods In this prospective study, 27 patients with suspected brachial plexopathy, received an imaging procedure composed sequentially of non-enhanced 3D-T2-STIR, CE-MRA, and contrast-enhanced 3D-T2-STIR, using a 1.5 T MR scanner. Signal intensities and contrast ratios were compared with and without contrast agent. The non-enhanced and contrast-enhanced 3D-T2-STIR images were mixed for two experienced radiologists to rate image diagnostic quality in a blind manner. 3D images of MRN and MRA were merged to reveal the spatial relation between brachial plexopathy and concomitant vascular disorders. Results By comparing the non-enhanced with contrast-enhanced 3D-T2-STIR images, it revealed that the use of the contrast agent in 3D-T2-STIR MRN could significantly suppress the background signals contributed by small vein (P < 0.001), lymph node (P < 0.001), muscle (P < 0.001) and bone (P < 0.001). This improved the contrast ratios between the brachial plexus and its surrounding tissues (P < 0.001) and boosted the image’s quality score (P < 0.01). Examining both CE-MRA and 3D-T2-STIR images revealed a relatively high incidence of concurrent vascular dysfunction in brachial plexopathy, with 39% of confirmed cases accompanied with subclavian and axillary vessel abnormalities. Conclusion Combining contrast-enhanced 3D-T2-STIR MRN with MRA at a 1.5 T system significantly suppresses background signals, improves brachial-plexus display, and provides a direct assessment for both brachial plexus lesion and surrounding vascular injury. | ||
| 650 | 4 | |a Brachial plexus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Magnetic resonance neurography |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Magnetic resonance angiography |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Contrast agent |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Brachial plexopathy |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Zhang, Tonghua |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jianxin |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Zongbao |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Yijiang |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jiahui |e verfasserin |4 aut | |
| 700 | 1 | |a Xue, Feifei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Magnetic resonance materials in physics, biology and medicine |d Heidelberg : Springer, 1993 |g 34(2020), 2 vom: 13. Juli, Seite 229-239 |w (DE-627)SPR00947773X |w (DE-600)1502491-X |x 1352-8661 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2020 |g number:2 |g day:13 |g month:07 |g pages:229-239 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10334-020-00867-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 33.07 |q ASE |
| 936 | b | k | |a 35.25 |q ASE |
| 936 | b | k | |a 44.64 |q ASE |
| 951 | |a AR | ||
| 952 | |d 34 |j 2020 |e 2 |b 13 |c 07 |h 229-239 | ||